Immunology of Cardiac Arrest and Lung Fibrosis
Brigham and Women's Hospital
Harvard Medical School
Pulmonary and Critical Care Medicine
Hale Building for Transformative Medicine
ekim11 at bwh.harvard.edu
Our collaborators
Research funding
1. DA-827785 (Edy Kim) Jul 1, 2021 - Jun 30, 2023
American Lung Association
Dalsemer Research Award in Interstitial Lung Disease (ILD): T cell-fibroblast axes drive early, unclassified ILD (uILD)
2. (Edy Kim) Jan 1, 2021 - Dec 31, 2023
AHA Transformational Project Award
I-CAN: A collaborative research network to discover immunological therapies for cardiac arrest
3. (Edy Kim) Jan 1, 2021 - Jun 30, 2021
USAID
COVIDprotocols.org
4. R01DK125786 (LEAF, DAVID EVAN) Sep 1, 2020 - Jun 30, 2025
NIH/NIDDK
DEFEROXAMINE FOR THE PREVENTION OF ACUTE KIDNEY INJURY
Role: Co-Investigator
5. (Edy Kim) Jan 1, 2020 - Dec 31, 2021
Brigham and Women's Hospital DOM Innovation Evergreen Fund
Discovery of novel immunological therapies for clinical cardiac arrest and resuscitation